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Hemopoietic Stem Cells: Stochastic
Differentiation and Humoral Control of
Proliferation
by Makio Ogawa*
The central feature ofhemopoiesis is life-long, stable cell renewal. This process is supported by hemopoietic
stem cells which, in the steady state, appear to be dormant in cell cycling. The entry into cell cycle ofthe
dormant stem cells may be promoted by such factors as interleukin-1, interleukin-6 (IL-6), and granulocyte
colony-stimulatingfactor(G-CSF). Once the stem cells leaveGo andbeginproliferation, the subsequentprocess
is characterized bycontinued proliferation anddifferentiation. While several models ofstem cell differenti-
ation have beenproposed, micromanipulation studies ofindividual progenitors suggestthatthe commitment
ofmultipotential progenitors to single lineages is a random (stochastic) process. The proliferation ofearly
hemopoietic progenitors requires the presence ofinterleukin-3 (IL-3), andthe intermediate process appears
to be supported by granulocyte/macrophage colony-stimulating factor (GM-CSF). Once the progenitors are
committed to individual lineages, the subsequent maturation process appears to be supported by late-acting,
lineage-specific factors such aserythropoietin andG-CSF. Synthesis ofahemopoietic factormaytakeplace
in different cell types and is regulated by multiple factors The physiological regulator oferythropoiesis is
erythropoietin, which, byafeedbackmechanism, provides finecontrol oferythrocyte production. Feedback
mechanisms for leukocyte production have not been identified. It is possible that there is no feedback regu-
lator ofleukopoiesis. In this model, leukocyte production in the steady state is maintained at a genetically
determined level. When an infection occurs, the bacterial lipopolysaccharides may augment the production
ofinterleukin la and(3, tumornecrosis factor, macrophage colony-stimulating factor, etc. These factors cir-
culate and stimulate the production in the marrow ofG-CSF, GM-CSF, IL-3, IL-6, etc., with resultant leu-
kocytosis. Once the infection subsides, the production ofthe factors and leukopoiesis return to the steady-
state levels.
Introduction
The central feature ofthe hemopoietic system is its con-
tinuous process of cell turnover. It is estimated that ap-
proximately 200 billion erythrocytes (1) and 60billion neu-
trophilic leukocytes (2) are produced and destroyed daily
in a man weighing 70 kg. This life-long cell renewal pro-
cess is supported by stem cells that possess the ability to
self-renew and to produce progenitors that are commit-
ted to differentiation in singlelineages. The mechanisms
regulating stem cell functions have intrigued not only
hematologists but also biologists interested in cellular
differentiation and have been the object of active inves-
tigations and model building. During the last three de-
cades, studies usingfunctional assays forhemopoietic pro-
genitors, i.e., the in vivo spleen colony assay for murine
stem cells (3) and clonal cell culture assays forprogenitors
at various stages ofdevelopment (4), have resulted in sig-
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nificant elucidation ofthe mechanisms ofhemopoiesis. In
addition, these assays allowed identification of several
types ofhemopoietic factors. Recent clinicaltrials indicate
that some ofthe recombinant proteins promise to be ef-
fective in the treatment with patients with hemopoietic
disorders. In this review, I will summarize first the cur-
rentunderstanding ofthe stem cell kinetics and differen-
tiation and second themechanisms ofthe hemopoietic fac-
tors regulating the dynamics of cell turnover.
Progenitors
General Consideration
Available evidence suggests that at a given time,
hemopoietic cells occupyingthe entire hemopoietic tissue
may be supplied by a small number of stem cell clones.
Mulligan and his associates (5,6) reconstituted the hemo-
poietic system of mice by transferring a retrovirally la-
beled clone ofstemcells, therebydemonstratingthatthe
descendants of a single stem cell can generate enoughM. OGAWA
cells to occupy the entire lympho-hemopoietic system.
Follow-up studies ofsuch animals indicated that hemopoi-
esis maybe supportedby sequential activation ofdifferent
stem cell clones (6). This clonal succession ofhemopoietic
stem cells in vivo had also been evinced by Mintz et al.
(7) who injected suspensions of liver cells from 13-day
mouse fetuses into the placental circulation of WIW or
Wf/Wf mice and obtained mice whose hemopoiesis was
supportedby more than one lone ofstem cells. Serial ob-
servations ofthe erythrocyte types up to 60 weeks after
transplantation revealed a complementary rise and fall in
the proportion ofthe cells ofdifferent genotypes. These
observations clearly demonstrated major proliferative
potentials of a single stem cell and the exponential in-
crease in the incidences of the progenitors as they pro-
gress through the developmental process.
Cell-Cycle Dormancy of Stem Cells
It is generally held that in the steady state, most
hemopoietic stem cells are notengaged inactiveprolifer-
ation. Experimental evidence for this concept has been
provided by investigators in several laboratories. Becker
et al. (8) demonstrated that short-term exposure to
3H-thymidine with high specific activity does not kill
colony-forming units in spleen (CFU-S). Similarly, multi-
lineage colonyformation inculture wasnotaffectedbythe
brief exposure to 3H-thymidine with high specific activ-
ity(9). Hodgson andBradley(10)reportedthathigh-dose
5-fluorouracil (5-FU), whichpreferentially kills cells in the
cell cycle, does not affect cells that form late-appearing
spleen coloniestermedpre-CFU-S In ourlaboratory, se-
quential observations of the growth of individual mul-
tipotentialprogenitors in culture alsosuggestedthatmost
primitive multipotential progenitors are dormant in cell
proliferation (11). The concept of atrue resting state was
originally proposed by Lajtha (12) and was based on
studies ofliver cell regeneration. He envisioned that this
state ismetabolically distinctfromthe otherphases ofthe
cell cycle, andcoined the termGo state. Lajthaproposed
thathemopoietic stem cells are inGo since cell-cycle dor-
mancy confers the stem cells time to repair DNA dam-
ageandthusallowsmaintenance ofthe geneticintegrity
ofthe stemcellpopulations (13). The mechanisms that ini-
tiatethecelldivisionofthe stem cells are not known. La-
tha proposed that this is a random process (13). As will
be discussed later in this review, there is evidence that
interleukin-1, interleukin-6, and granulocyte colony-
stimulating factors appear to shorten the Go period and
mayinducethe stemcells tobeginactive proliferation. It
is possible that these factors, like the other hemopoietic
factors, act as survival and/orgrowth factors on the most
primitive hemopoietic stem cells andthat the survival of
stem cellsandthe duration ofGo state maydepend onthe
ambient levels ofthese factors.
Self-Renewal ofStem Cells
When a stem cell divides, its progeny can self-renew or
differentiate. Following the development of the spleen
colony assay, Till and his associates (14) transplanted
single-cell suspensions ofindividual spleen colonies into
secondary recipient mice and observed a very heter-
ogeneous distribution ofthe incidences of CFU-S in in-
dividual spleencolonies. Thefrequencydistribution could
not be fitted by a Poisson distribution but could be ap-
proximatedby a y distribution (14). Simultaneously, they
caried out a computer simulation of a birth and death
model inwhichtheyenvisionedthat self-renewal ofCFU-
S is a birth process and that loss ofcolony-forming abil-
ityassociatedwith differentiationis adeathprocess. This
simulation of the model based on generation of random
numbers also resulted in a y distribution ofCFU-S inci-
dences. Based on these data, they proposed that self-
renewal ordifferentiation is astochastic(random)process.
In our laboratory, we analyzed distributions ofcolony-
formingcells forblast cell colonies andthose ofmultiline-
age coloniesbyreplatingindividual blast cell colonies. We
assumed that the blast cell colony formation and mul-
tilineage colony formation represent the culture equiva-
lent of the birth and death processes, respectively (15).
The frequency distributions of the secondary blast cell
colonies andmultilineage colonies couldbe approximated
by variates of y distributions. Therefore, the studies in
vivoandin culture mutuallycorroborated and were con-
sistent with the concept that self-renewal and commit-
ment to differentiation of an individual stem cell is a
stochastic process.
We also carried out serial observations(mapping)ofthe
development multi-potential blast cell colonies (11) from
spleen cellsof5-FU-treated mice(10). Blast cell colonies
emerged after variable lag times and once identified,
grewwith relatively fixed cell doubling times and devel-
opedintomultilineage colonies. These observations were
consistentwiththenotionthatinthe steady-statethe dor-
mant stem cells enter cell-cycle randomly and that once
committedto differentiation, theirprogenyproliferate at
a relatively constant cell doubling time.
Differentiation ofStem Cells
Several models for stem cell differentiation have been
proposed(16). Two deterministicmodelsproposethatex-
ternal factors instruct individual stem cells regarding
their directions ofdifferentiation. Thehemopoietic induc-
tive microenvironment(HIM)modelofTrentinand his as-
sociates(17,18)features small anatomical niches that are
specificforindividuallineages and determinethe commit-
mentofstemcells. The stemcellcompetitionmodel envi-
sions controlofstemcelldifferentiationbylineage-specific
humoral factors. For example, VanZant and Goldwasser
(19,20)proposedthat exposure ofa stem cell in a certain
cell cycle phase to erythropoietin or colony-stimulating
factors determines the commitment to the erythroid or
granulocytic lineage. In addition, a model of predeter-
mined, sequential loss oflineagepotentialshasbeenpro-
posed (21). As discussed previously in our review (16),
specific cziticisms maybe raised againstthe datasupport-
ing these models. Most importantly, these models are
based on studies of populations of colony-forming cells
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rather than on individual progenitors. Identification of
murine blast cell colonies with high replatingefficiencies
(22) provided us with a unique opportunity to micro-
manipulate single progenitors and study differentiation
potentials of single stem cells.
When we carried out cytological analysis ofmultiline-
age colonies that were derived from single progenitor
cells andwere culturedunderidentical conditions, weob-
served varying lineage combinations expressed in in-
dividual colonies (23). Subsequently, studies ofpaired pro-
genitors revealed heterologous pairs of single and
multilineage colonies expressing diverse lineage com-
binations (24). These results were consistentwiththe con-
cept that the lineage selection by the progenitors at the
time of cell division is a random process. Sequential
manipulation of paired progenitors and analysis of the
differentials ofcolonies derived fromthese progenitors in-
dicated that the apparent random commitment takes
place sequentially during stem cell differentiation (25).
Analysis ofsingle and paired human progenitors also re-
vealed similar results andwere consistent with the notion
that the principle ofhuman stem cell differentiation is a
random restriction in the types and number of lineage
potentials (26,27).
Inthe analysisofhumanmultilineage colonies ofsingle
cell origin, we observed thatindividual lineages were rep-
resented by a variable number of cells. For example, a
mixed colony consisted of 1340 erythrocytes and 4 eosi-
nophilic leukocytes (26). This observation suggested that
the numberoftimes that aprogenitor divides after com-
mitment to a single lineage is variable. This observation
is also in agreement with earlier observations in replat-
ing analysis ofsingle lineage colonies. Investigators had
observed variable replating efficiencies and heterogene-
ous size distributions ofsecondarycolonies. Forexample,
Wu (28)reported that the cumulative frequency distribu-
tion ofthe numbers ofsecondary T-lymphocyte colonies
perprimaryT-lymphocyte colony couldbe approximated
by ay distribution. Analysis ofthe size ofsecondarymast
cell colonies and computer simulation ofamodification of
thebirthand deathmodel ofTill etal. (14)also suggested
that mast cell proliferation in culture is a stochastic pro-
cess (29). Ibgether these data are consistent with the no-
tion that both differentiation and proliferation of
hemopoietic progenitors are separate stochastic pro-
cesses.
Humoral Factors
General Considerations
While differentiation may be a stochastic process,
proliferation and survival ofprogenitors appearto be un-
derthe control ofhumoral factors. Recently, anumberof
hemopoietic factors have been identified, purified, and
molecularly cloned. Themajorhemopoieticfactorsinclude
erythropoietin (Ep) (30-32), a physiological regulator of
erythropoiesis; granulocyte/macrophage colony-
stimulatingfactor(GM-CSF)(33-36);granulocyte(G)CSF
(37-39); interleukin-3 (IL-3) (40-43); and macro-
phage/monocyte (M)-CSF (44-46). Except for Ep, the
physiological roles of these factors have not yet been
clearly established. However, recent clinical trials ofsome
ofthe factors indicate that they may possess significant
therapeutic potential in the treatment of some of the
hemopoietic disorders. Readers are referred to recent
reviews(47-49)for detailedinformation onthebiosynthe-
sis, biochemistry and molecularbiology ofthese proteins.
G-CSF was initially identified as a differentiation-
inducingfactorforleukemic cell lines (37). Some investi-
gators have proposed that hemopoietic factors induce
differentiation ofprogenitors in normal hemopoiesis. As
reviewed earlier, our micromanipulation studies of
differentiation ofsingle andpairedprogenitors suggested
that stemcell differentiation isnotadirectedprocess. The
primary function ofthe humoral factors is to support the
survival and/orproliferation ofhemopoietic progenitors.
In this model, the apparent induction ofdifferentiation is
amere reflection ofsurvival/proliferation ofapopulation
ofprogenitorsthatare supportedbyahumoralfactorand
the death ofpopulations ofprogenitors that are not sup-
portedbythefactor. Based on these concepts, I have sum-
marized the recent evidence on the targets of the in-
dividual hemopoietic progenitors. The factors are
arbitrarily dividedintolate-acting,lineage-specificfactors,
early-acting, lineage-nonspecific factors and those affect-
ing dormant stem cells. The proliferative kinetics ofthe
stem cells and the targets ofthe major hemopoietic fac-
tors are schematically presented in Figure 1.
Late-Acting, Lineage-Specific Factors
Ep is aphysiological regulator oferythropoiesis and is
secretedbythe kidney. Therecombinantprotein hasbeen
given to patients with chronic renal failure and intracta-
ble anemia with remarkable therapeutic success (50).
While some controversy still exists, the cells that are the
most sensitive to Ep appearto be late erythroidprogen-
itors that include erythroid colony-forming units (CFU-
E)(51), erythroid cluster-formingunits (52), and pronor-
moblasts. Since these cells are present inlarge numbers,
are close to terminal maturation and are activelyengaged
c
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FIGURE 1. The model depicts the cell cycle dormancy ofthe stem cells
and active proliferation oftheir progenies once they begin differen-
tiation. It also illustrates the principle targets of the major
hemopoietic factors.
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in cell proliferation, a slightfluctuation inthe ambient Ep
levelswouldresult inrapidchanges intheproduction and
release ofreticulocytes. Experimental data suggestthat
multipotential stem cells (53) and early erythroid progen-
itors (54-56) are not under the control of Ep.
G-CSF appears to be a late-acting, neutrophil-specific
factor. It has been demonstrated that in serum-containing
cultures G-CSF supports theformation ofneutrophil/mac-
rophage colonies and pure neutrophil colonies (57),
whereas in serum-free culture, it supports formation of
onlyneutrophil colonies(58). Inourlaboratory, we studied
the effects ofG-CSF alone andin combinationwith other
factorsoncolonyfonnationbypurifiedhumanprogenitors
in serum-free culture(59). G-CSF revealed significant syn-
ergism with earlier-acting factors such as IL-3 and GM-
CSF in support of the formation of neutrophil colonies.
WhenG-CSF wasinjectedinto animals, promptand dose-
dependent neutrophilic granulocytosis was observed
(60-62). In addition, the differential revealed predomi-
nance ofmature neutrophils (61). Together, these obser-
vations support the concept that G-CSF is a late-acting,
neutrophil-specific factor. Interestingly, G-CSF appears
also to play arole in stimulation ofactive proliferation of
dormant stem cells. This will be elaborated in more de-
tail later.
M-CSF has longbeen considered as alate-acting macro-
phage/monocyte-specific factor. Recently, CSF-HU that
is abundant in humanurine (63) was proved to be human
M-CSF (46). A clinical trial ofthismaterialproducedmod-
est elevation in the granulocyte and macrophage counts
in patients (63). It was also reported that during preg-
nancy, there is concomitant increase in the serum levels
ofM-CSF andblood monocyte counts (64). In serum-free
culture ofpurified humanprogenitors, M-CSF alone orin
combination with GM-CSF, G-CSF, IL-3, and Ep was an
ineffective factor for macrophage colony formation (59).
It ispossible that M-CSF needs to interact with otherfac-
tors in serum in macrophage colony fornation.
Early-Acting, Lineage-Nonspecific Factors
IL-3 appears to be animportantfactorforproliferation
of early hemopoietic progenitors. Purified murine IL-3
supports the growth ofvarious types ofcolonies, includ-
ing multilineage colonies (65-67) and blast cell colonies
(66,68). Gibbon IL-3, which is 93% homologous with hu-
man IL-3, supported the formation of human multiline-
age and blast cell colonies (69). We also observed that
delayed addition ofmurine IL-3 to cultures 7 days after
cellplatingdecreasesthenumber ofmultipotential blast
cell colonies to one-halfthe number in cultures with IL-3
added on day 0. It did not, however, alter the prolifera-
tive and differentiative characteristics oflate-emerging,
multipotential blast cell colonies (66).
Based on these observations, we proposed that IL-3
does nottrigger stem cells into activeproliferation butis
required forthe continuedproliferation ofearlymultipo-
tential progenitors. Subsequently, we observed that the
development ofmultipotentialblast cell coloniesrequires
less IL-3 than the process ofmultilineage colony forma-
tionfrom blast cell colonies (68). These observations sug-
gestedthatduring stemcell development, theearlymulti-
potential progenitors are sensitive to IL-3, whereas as
theygradually differentiate, the sensitivityto IL-3 slowly
declines.
More recently, we examined the effects ofhuman IL-3
on colony formation bypurified hemopoietic progenitors
in serum-free culture. IL-3 alonewasnot effective in sup-
port ofcolony formation except forafew small eosinophil
colonies (59). Serial observation ofthe serum-free culture
dishes containing human IL-3 revealed that blast cell
clusters appear after varying lag time, reach approxi-
mately the 50 cell stage, and degenerate in the absence
oflate-acting, lineage-specific factors. IL-3 revealed sig-
nificant synergism with Ep and G-CSF in support of
erythroid bursts and neutrophil colonies, respectively.
These observations indicated that IL-3 supports progen-
itors that are in the early stages ofhemopoietic develop-
ment, but it does not support the terminal maturation
process (59).
The primary function ofGM-CSF may also be to sup-
port the intermediate stages ofhemopoietic development.
It may not support the terminal neutrophil/macrophage
maturation process effectively. Although itwas originally
identified as the factor that supported neutrophil/macro-
phage colonies in culture, Metcalf et al. (70) in 1980 ob-
servedthatthe few cell divisions ofmultipotentialprogen-
itors are supported by murine GM-CSF. Using serial
transfer ofmultipotential blast cell colonies, we demon-
stratedthat asubpopulation ofthemultipotentialprogen-
itors that respond to IL-3 also respond to GM-CSF (71).
Investigators in severallaboratories(72-74)havereported
that human GM-CSF supportsmultilineage colony forma-
tion in serum-containing culture andpossesses significant
burst-promoting activity (BPA). In the studies ofhuman
enrichedprogenitors in serum-free culture, we observed
thatGM-CSF alone didnot support colonyformation ex-
cept for a few small eosinophil colonies (59). However, in
combination with G-CSF and Ep, GM-CSF effectively
supported a large number of neutrophil colonies and
erythroid bursts. Recently, administration ofthe recom-
binantGM-CSF toprimates(75,76) andpatients with ac-
quired immunodeficiency syndrome (77) raised the levels
of circulating neutrophils, eosinophils, and monocytes.
These observations indicate that the primary target of
GM-CSF isapopulationofmultipotentialprogenitors that
are intermediate between those responding to IL-3 and
those sensitive to late-acting, lineage-specific factors.
Factors That Affect Proliferation of
Dormant Hemopoietic Stem Cells
Very recently, several factors have been identified that
appear to induce proliferation ofhemopoietic stem cells
in Go. Stanley and his co-workers (78) reported that
hemopoietin-1 (H-1), which waspurifiedfromhumanblad-
dercarcinoma cellline, 5637(79), acts synergisticallywith
IL-3 in support of proliferation of murine hemopoietic
stem cells. The recent reports by Mochizuki and her as-
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sociates (80)andMoore andWarren(81)suggestthat IL-1,
whichis abundant in the supernatant ofthis cellline, may
account for the H-1 activity.
In ourlaboratory, we have found IL-6[also calledinter-
feron P2 (82) and B-cell stimulatory factor-2 (83)] to pos-
sess synergistic activity with IL-3 in the support ofthe
active proliferation ofmurine hemopoietic stem cells (84).
Inthe presence ofIL-3, multipotential blastcell colonies
emerged after varying lag times from spleen cells of
5-FU-treated mice (66,84). When IL-6is also present, the
appearance ofmultipotential blast cell colonies is signifi-
cantly hastened, although the speed ofthe development
ofthe blast cell colonies was not affected(84). These data
suggested thatpartofthe H-1 effectofIL-6isthe appar-
ent shortening oftheGoperiodofhemopoietic stemcells.
Human IL-6 also works synergistically with human
IL-3 in stimulation oftheproliferationofearlyhumanpro-
genitors (85). Mostrecently, we have identified human G-
CSF as an additional synergistic factor for the
IL-3-dependent proliferation ofmurine hemopoietic stem
cells (86). Both G-CSF and IL-6 appear to possess
stronger synergistic effectsthan IL-1. Itisofinterestthat
there appears to be structural similarity between IL-6
and G-CSF including the positions of the cysteine
residues, indicating similarity in three-dimensional struc-
tures ofthe twoproteins. Itispossible thatthe genesfor
the two proteins may share a common ancestral gene.
There are experimental data to indicate thatproduction
ofIL-1, IL-6, andG-CSF maybe significantly augmented
immediatelyafterinvasionbymicroorganisms. Forexam-
ple, bacteriallipopolysaccharides induce synthesis ofIL-1
in macrophages (87). IL-1 then circulates inthebodyand
may augment synthesis ofG-CSF (88,89) and IL-6(90,91)
byfibroblasts andothercell types. G-CSF stimulates the
production ofneutrophils, and IL-6 enhances maturation
ofB-cells andtherebythe synthesis ofimmunoglobulins.
The additional effects of these factors on hemopoietic
stem cells in Go may assure an uninterrupted supply of
thehemopoietic andpossiblylymphoidprogenitorsforan
integrated and effective defense against bacterial infec-
tions.
Factors Regulating Other Lineages
Regulation ofmegakaryopoiesis andthrombopoiesis re-
mains unclear. While several factors such asmegakaryo-
cyte-CSF (92) and megakaryocyte stimulatory factor,
which enhances synthesis ofplatelet-specific proteinsby
a rat megakaryoblast cell line (93), have been purified,
their roles in the physiology of megakaryopoiesis and
thrombopoiesis in vivo have not been established.
The proliferation ofmast cells appears to be regulated
by IL-3 and IL-4. Several years ago, investigators in a
numberoflaboratories succeededingrowingmurinemast
cellsinsuspension culture inthepresence ofmedium con-
ditioned by pokeweed mitogen-stimulated spleen cells
(PWM-SCM) (94-97). IL-3 was identified to be the main
factorin PWM-SCM. However, IL-3 couldnotsupportthe
continued proliferation of mast cells in suspension cul-
tures. Inaddition, it wasfound that IL-3 supportsprimar-
ily proliferation ofmucosal-type mast cells but not con-
nective tissue-type mast cells. More recently, IL-4 (98)
[also known as B-cell stimulatory factor-1 (99)]was found
to be an additional mast cell stimulating factor and was
identified asthefactorthatisneededfortheproliferation
ofconnective tissue-type mast cells(100). The roles ofhu-
man IL-3and IL4 intheproliferationofhumanmastcells
have not been established.
Several factors have been shown to stimulate prolifer-
ation ofeosinophils recently. Previously, several investi-
gators documented that the human andmurine GM-CSF
and IL-3 support eosinophil proliferation inmethylcellu-
lose culture (66,68,69,72-74). In addition, in vivo admin-
istration ofhuman GM-CSF inmonkeys andmen(75-77)
revealed significant augmentation of the number of cir-
culating eosinophils. Recently, Sanderson and his col-
leagues (101)identified eosinophil differentiation factorin
the supernatant of cultures ofalloreactive T-cell clones.
This factor proved to be identical to T-cell replating fac-
tor (102) and is generally referred to as interleukin-5
(IL-5). The exactrelationship between IL-5, GM-CSF, and
IL-3 in eosinophilopoiesis remainsyet to be determined.
Control ofHemopoiesis-A Model of
Granulopoiesis
In addition to the factors already described, there are
a number of factors known to affect hemopoiesis in-
directly. Foremost, IL-ia andp appeartoplaymajorroles
ingranulocyte/macrophage production. The synthesis of
IL-1 by macrophages may be augmented by bacterial
lipopolysaccharides (87). IL-1 thenaugmentstheproduc-
tion and the release of G-CSF (88,89) and GM-CSF
(88,103-106)byavarietyofcells, includingfibroblasts, en-
dothelial cells, and smooth muscle cells. Tumor necrosis
factors (TNF a and TNF P) and interferons are known to
inhibitmyeloidproliferation in culture. Aconfusingaspect
isthat TNFa canstimulate themesenchymal cellsto syn-
thesize and release G-CSF (107) and GM-CSF (108,109).
It was reported that GM-CSF may in turn augment the
synthesis and release ofTNFa by monocytic cells (110).
IL-4 mayindirectlyinfluence proliferation ofprogenitors
supported by other cytokines (111,112). These observa-
tions indicate that a complex network ofthe cellular and
molecular interactions regulate the continuous cellular
production in hemopoiesis.
Itisgenerally heldthatthefeedbackmechanisms exist
for the control ofindividual lineages. In erythropoiesis,
tissue oxygenation andEpprovidethefeedbackfine con-
trol ofcellproduction. Regardingotherlineages, nofeed-
backsystemhasbeenidentified. Itispossiblethatthere
is no such feedback regulation existing for granulocyte
production. In this model, the production of granulo-
cyte/macrophages inthe steady state ismaintainedatge-
netically determined levels and is augmented onlyby ex-
ternal stimuli such as infections. In the presence of
infections, bacterial lipopolysaccharides, IL-1 andTNFa
willbe involvedinthe augmentation ofthe synthesis and
release ofG-CSF andGM-CSF byvarioustypesofmesen-
chymal cells as outlined above. These factors, produced lo-
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cally in thebone marrow, inturn augment theproduction
ofneutrophils, macrophages, and eosinophils Once the ex-
ternal stimuli are removed, the production ofthe leuko-
cytes reverts back to the steady-state level. Since the
lifespans ofleukocytes are brief, only coarse regulation
ofthe cellular proliferation may be necessary. The wide
normal ranges ofgranulocyte counts may attest to this
hypothesis
This work was supported by NIH grant AM32294 and the Veterans
Administration. M. Ogawa is a Veterans Administration Medical Inves-
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